Posterior Cortical Atrophy Clinical Trial
— REEDUC-ACPOfficial title:
Development and Evaluation of the Effectiveness of Rehabilitation Tools for Neurovisual Disorders in Patients With Posterior Cortical Atrophy (PCA)
Verified date | February 2023 |
Source | Centre Hospitalier Universitaire de Nice |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Posterior cortical atrophy (PCA) is manifested by neuro-visual disorders that alter the spatial location of objects, their manipulation and/or recognition. Its etiology is most often neurodegenerative, with a major impact on the autonomy and mood of patients and their families. Few studies have focused on non-medication management of these disorders. The present study thus has a double objective: the development of a complete tool to work on the recognition, localization and/or manipulation of objects; and the evaluation of the effectiveness of this type of management.
Status | Completed |
Enrollment | 3 |
Est. completion date | June 15, 2022 |
Est. primary completion date | June 15, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 50 Years and older |
Eligibility | Inclusion Criteria: - Age >50 years old - Male or Female - Patients with a diagnosis of PCA according to the criteria of Tang-Wai et al (2004) - MMS>15 - Voluntary, written and informed consent of the patient himself or its legal representative (guardian/curator), with oral consent of the patient in all cases - Anti-Alzheimer's and psychotropic treatments stable for one month, if taken by the patient - Affiliation to a social security system Exclusion Criteria: - Uncorrected visual disorders with non-degenerative etiology (AV<0.5) - Person under the protection of justice - Pregnant women (a pregnancy test will be performed in premenopausal women) |
Country | Name | City | State |
---|---|---|---|
France | Institut Claude Pompidou - Centre Mémoire de Ressources et de Recherche du CHU de Nice | Nice | Alpes-Maritime |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire de Nice |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Effectiveness evaluation | Effectiveness will be evaluated a score based on success rate (from 0 to 10), reaction time and eye-recording . | At week 34 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01095744 -
Influence of Age on Amyloid Load in Alzheimer's Disease and in Atypical Focal Cortical Alzheimer's Disease
|
N/A | |
Recruiting |
NCT03153371 -
Early-onset Alzheimer's Disease Phenotypes: Neuropsychology and Neural Networks
|
||
Not yet recruiting |
NCT04150198 -
MECHANISMS OF NEURONAL RESILIENCE IN ALZHEIMER'S DISEASE AND ITS FOCAL VARIANTS: A PET/MR STUDY
|
N/A |